Mast Cell Activation Syndrome and the Triad of MCAS, POTS, and Hypermobile EDS
- 14 November 2024
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 120 (7) , 1429-1433
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 18 references indexed in Scilit:
- Mast Cell Activation Syndrome and Gut Dysfunction: Diagnosis and ManagementCurrent Gastroenterology Reports, 2024
- Getting the BS out of Irritable Bowel Syndrome with Diarrhea (IBS-D): Let’s Make a DiagnosisCurrent Gastroenterology Reports, 2023
- Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell DisordersThe Journal of Allergy and Clinical Immunology: In Practice, 2023
- Overlap of disorders of gut–brain interaction: a systematic review and meta-analysisThe Lancet Gastroenterology & Hepatology, 2023
- Systemic mast cell activation disease variants and certain genetically determined comorbidities may be consequences of a common underlying epigenetic diseaseMedical Hypotheses, 2022
- Some cases of hypermobile Ehlers–Danlos syndrome may be rooted in mast cell activation syndromeAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2021
- Mast cell activation symptoms are prevalent in Long-COVIDInternational Journal of Infectious Diseases, 2021
- Mast Cell Activation Syndrome: A Primer for the GastroenterologistDigestive Diseases and Sciences, 2020
- Characterization of Mast Cell Activation SyndromeThe American Journal of the Medical Sciences, 2017
- Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseasesBrain, Behavior, and Immunity, 2015